Oncology Studies Corrective Action Plans for Lasting Improvement

Suzanne Neve, RHIA, CTR - Director, Cancer Registry Oncology Leave a Comment

Corrective action is an aspect of quality management that focuses on rectifying a task, process, product, service, or individual behaviors when any of these factors produce errors, deviate from the original plan or benchmarks. Corrective actions can be thought of as an improvement an organization uses to eliminate undesirable or ineffective outcomes. In this seventh, and...

Oncology Quality Studies: Benchmarking Oncology Data

Suzanne Neve, RHIA, CTR - Director, Cancer Registry Oncology 1 Comment

In our sixth installment in this series on oncology quality studies we will look at the value, challenges, and recommendations for benchmarking oncology data.   Benchmarking is an excellent way to identify opportunities to enhance clinical practices, workflows, procedural efficiency, cost-effectiveness, utilization, and financial outcomes. There are many sources for...

Oncology Quality Studies: Prepare the Summary Analysis

Suzanne Neve, RHIA, CTR - Director, Cancer Registry Oncology Leave a Comment

In this fifth installment of our series on oncology quality studies we will discuss the preparation and writing of the summary analysis and study results. See links for parts 1-4 below.  Although there are no official content outlines for writing the final report, it is important to have a written document that states the project’s goals, lists the strategies used to...

Oncology Quality Studies: Study Conduct and Data Collection (Part 4)

Suzanne Neve, RHIA, CTR - Director, Cancer Registry Oncology Leave a Comment

In this fourth installment of our series on oncology quality studies we will talk about conducting the study according to the planned methodology or quality measures and how to organize the data collection process. The methodology is the roadmap, or strategy, that describes the way the study is to be conducted and identifies the methods to be used during the process. The...

Driving Data into the Future: NCRA Conference Overview

Michele Webb CTR NCRA 1 Comment

On June 3 – 5, 2021 cancer registrars across the country came together for the National Cancer Registrar’s Association (NCRA) 47th Annual Educational Conference. This year’s event was held virtually and offered up to 29.25 continuing education (CE) hours featuring workshops and presentations from the standard-setting agencies and cancer registry community. Conference...

Oncology Quality Studies: Planning and Methodology (Part 3)

Suzanne Neve, RHIA, CTR - Director, Cancer Registry Oncology Leave a Comment

We have covered the first two steps in this multi-part series. In Step 1 we talked about assembling a team of experts to participate in the study project. In step 2 we identified the problem statement. Now, in Step 3 we will look how the study is conducted and the methodology used to structure the analysis.   Quality studies are, by intent, a process that is used to help...

Oncology Quality Studies: Identifying the Problem

Suzanne Neve, RHIA, CTR - Director, Cancer Registry Oncology Leave a Comment

Quality studies and improvements have much more value than merely meeting a cancer program standards requirement. If planned well and properly conducted, quality studies can energize the members of the team, reduce inefficiencies, increase cost effectiveness, and deliver value to the organization and patients it serves.   Read Part 1 of this article series HERE.  The...

Oncology Quality Studies: Creating a Team of Subject Matter Experts

Suzanne Neve, RHIA, CTR - Director, Cancer Registry Oncology Leave a Comment

There is a Japanese proverb that says, “Vision without action is a daydream. Action without vision is a nightmare.” When cancer programs start establishing the quality initiative activities each year, they should set aside time to plan and explore proposed topics before launching into analysis or implementing solutions. Failure to take plan or methodically conduct a study...

Understanding the Functions of Different Chemotherapy Agents

Suzanne Neve, RHIA, CTR - Director, Cancer Registry Oncology 1 Comment

Chemotherapy is one of many treatment options for patients with cancer. This form of therapy uses chemical agents (i.e., anti-cancer or cytotoxic drugs) that interact with cancer cells to eradicate or control the growth of cancer. Common alternative forms of treatment include surgery to remove all or a portion of a tumor as well as radiation therapy, hormone therapy, and...

Quality Improvement Meets Oncology

Suzanne Neve, RHIA, CTR - Director, Cancer Registry Oncology Leave a Comment

Why QOPI Programs Matter Quality Oncology Practice Initiative programs are designed for hematology-oncology physician-based practices. Strictly voluntary, QOPI programs provide a valuable tool to assess current practice standards. QOPI Methods and Measurement Chart abstraction is performed twice a year, spring and fall, and covers a five week period. During this...

Sign Up For MRA Blog Updates!

Recent Posts